Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 25 | $1,960,687 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
26 May 2022 17:09 | KALA | Kala Pharmaceuticals Inc | RA CAPITAL MANAGEMENT, L.P. | 10% | 26 May 2022 | Sale | 1,005,686 | 0.3636 | 365,667 | I |
25 May 2022 17:17 | KALA | Kala Pharmaceuticals Inc | RA CAPITAL MANAGEMENT, L.P. | 10% | 25 May 2022 | Sale | 1,434,509 | 0.42 | 602,494 | I |
25 May 2022 17:17 | KALA | Kala Pharmaceuticals Inc | RA CAPITAL MANAGEMENT, L.P. | 10% | 24 May 2022 | Sale | 144,805 | 0.51 | 73,851 | I |
25 May 2022 17:17 | KALA | Kala Pharmaceuticals Inc | RA CAPITAL MANAGEMENT, L.P. | 10% | 23 May 2022 | Sale | 1,250,000 | 0.65 | 812,500 | I |
05 Jan 2024 16:04 | KALA | KALA BIO Inc | IWICKI MARK T | CHIEF EXECUTIVE OFFICER | 04 Jan 2024 | Sale | 4,539 | 6.73 | 30,547 | D |
05 Jan 2024 16:05 | KALA | KALA BIO Inc | BRAZZELL ROMULUS K | SEE REMARKS | 04 Jan 2024 | Sale | 1,617 | 6.74 | 10,899 | D |
05 Jan 2024 16:06 | KALA | KALA BIO Inc | KHARABI DARIUS | CHIEF BUSINESS OFFICER | 04 Jan 2024 | Sale | 1,385 | 6.73 | 9,321 | D |
05 Jan 2024 16:07 | KALA | KALA BIO Inc | TRACHTENBERG ERIC | SEE REMARKS | 04 Jan 2024 | Sale | 1,227 | 6.74 | 8,270 | D |
05 Jan 2024 16:03 | KALA | KALA BIO Inc | BAZEMORE TODD | SEE REMARKS | 04 Jan 2024 | Sale | 1,405 | 6.74 | 9,470 | D |
05 Jan 2024 16:04 | KALA | KALA BIO Inc | REUMUTH MARY | CHIEF FINANCIAL OFFICER | 04 Jan 2024 | Sale | 1,227 | 6.74 | 8,270 | D |
06 Jan 2023 20:00 | KALA | Kala Pharmaceuticals Inc | IWICKI MARK T | CHIEF EXECUTIVE OFFICER | 04 Jan 2023 | Sale | 198 | 28.54 | 5,651 | D |
06 Jan 2023 20:00 | KALA | Kala Pharmaceuticals Inc | BAZEMORE TODD | SEE REMARKS | 04 Jan 2023 | Sale | 62 | 28.54 | 1,769 | D |
06 Jan 2023 20:00 | KALA | Kala Pharmaceuticals Inc | BRAZZELL ROMULUS K | SEE REMARKS | 04 Jan 2023 | Sale | 73 | 28.53 | 2,083 | D |
06 Jan 2023 20:00 | KALA | Kala Pharmaceuticals Inc | REUMUTH MARY | CHIEF FINANCIAL OFFICER | 04 Jan 2023 | Sale | 60 | 28.54 | 1,712 | D |
06 Jan 2023 20:00 | KALA | Kala Pharmaceuticals Inc | TRACHTENBERG ERIC | SEE REMARKS | 04 Jan 2023 | Sale | 60 | 28.55 | 1,713 | D |
28 Oct 2022 16:15 | KALA | Kala Pharmaceuticals Inc | IWICKI MARK T | CHIEF EXECUTIVE OFFICER | 26 Oct 2022 | Sale | 561 | 6.52 | 3,658 | D |
28 Oct 2022 16:15 | KALA | Kala Pharmaceuticals Inc | BRAZZELL ROMULUS K | SEE REMARKS | 26 Oct 2022 | Sale | 261 | 6.51 | 1,699 | D |
28 Oct 2022 16:15 | KALA | Kala Pharmaceuticals Inc | REUMUTH MARY | CHIEF FINANCIAL OFFICER | 26 Oct 2022 | Sale | 194 | 6.51 | 1,263 | D |
28 Oct 2022 16:15 | KALA | Kala Pharmaceuticals Inc | BAZEMORE TODD | SEE REMARKS | 26 Oct 2022 | Sale | 214 | 6.51 | 1,393 | D |
28 Oct 2022 16:15 | KALA | Kala Pharmaceuticals Inc | TRACHTENBERG ERIC | SEE REMARKS | 26 Oct 2022 | Sale | 194 | 6.52 | 1,265 | D |
29 Jun 2022 20:09 | KALA | Kala Pharmaceuticals Inc | IWICKI MARK T | CHIEF EXECUTIVE OFFICER | 27 Jun 2022 | Sale | 7,975 | 0.37 | 2,951 | D |
29 Jun 2022 20:10 | KALA | Kala Pharmaceuticals Inc | BAZEMORE TODD | SEE REMARKS | 27 Jun 2022 | Sale | 3,092 | 0.37 | 1,144 | D |
29 Jun 2022 20:11 | KALA | Kala Pharmaceuticals Inc | BRAZZELL ROMULUS K | SEE REMARKS | 27 Jun 2022 | Sale | 3,144 | 0.37 | 1,163 | D |
29 Jun 2022 20:12 | KALA | Kala Pharmaceuticals Inc | REUMUTH MARY | CHIEF FINANCIAL OFFICER | 27 Jun 2022 | Sale | 2,613 | 0.37 | 967 | D |
29 Jun 2022 20:12 | KALA | Kala Pharmaceuticals Inc | TRACHTENBERG ERIC | SEE REMARKS | 27 Jun 2022 | Sale | 2,613 | 0.37 | 967 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)